ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 109 filers reported holding ANTARES PHARMA INC in Q4 2017. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,199,000 | +6.1% | 275,000 | 0.0% | 0.19% | -2.1% |
| Q1 2021 | $1,130,000 | +3.0% | 275,000 | 0.0% | 0.19% | +2.1% |
| Q4 2020 | $1,097,000 | +47.6% | 275,000 | 0.0% | 0.19% | +24.5% |
| Q3 2020 | $743,000 | +1.9% | 275,000 | 0.0% | 0.15% | -2.6% |
| Q2 2020 | $729,000 | +16.8% | 275,000 | 0.0% | 0.16% | -3.1% |
| Q1 2020 | $624,000 | -51.7% | 275,000 | 0.0% | 0.16% | -48.2% |
| Q4 2019 | $1,293,000 | +40.5% | 275,000 | 0.0% | 0.31% | +19.3% |
| Q3 2019 | $920,000 | +1.7% | 275,000 | 0.0% | 0.26% | +7.5% |
| Q2 2019 | $905,000 | +8.6% | 275,000 | 0.0% | 0.24% | +23.0% |
| Q1 2019 | $833,000 | +6.7% | 275,000 | 0.0% | 0.20% | +31.5% |
| Q4 2018 | $781,000 | -15.5% | 275,000 | 0.0% | 0.15% | +0.7% |
| Q3 2018 | $924,000 | +30.1% | 275,000 | 0.0% | 0.15% | +20.3% |
| Q2 2018 | $710,000 | +17.4% | 275,000 | 0.0% | 0.12% | +8.8% |
| Q1 2018 | $605,000 | +10.6% | 275,000 | 0.0% | 0.11% | +7.6% |
| Q4 2017 | $547,000 | -38.6% | 275,000 | 0.0% | 0.10% | -45.6% |
| Q3 2017 | $891,000 | +0.6% | 275,000 | 0.0% | 0.19% | -4.9% |
| Q2 2017 | $886,000 | +13.4% | 275,000 | 0.0% | 0.20% | +4.6% |
| Q1 2017 | $781,000 | +21.8% | 275,000 | 0.0% | 0.19% | +10.9% |
| Q4 2016 | $641,000 | +38.7% | 275,000 | 0.0% | 0.18% | +29.6% |
| Q3 2016 | $462,000 | +883.0% | 275,000 | +896.8% | 0.14% | +694.1% |
| Q3 2015 | $47,000 | -17.5% | 27,587 | 0.0% | 0.02% | -10.5% |
| Q2 2015 | $57,000 | -25.0% | 27,587 | -2.0% | 0.02% | -26.9% |
| Q1 2015 | $76,000 | +5.6% | 28,137 | 0.0% | 0.03% | 0.0% |
| Q4 2014 | $72,000 | +41.2% | 28,137 | 0.0% | 0.03% | +36.8% |
| Q3 2014 | $51,000 | -62.2% | 28,137 | -44.3% | 0.02% | -61.2% |
| Q2 2014 | $135,000 | -23.7% | 50,550 | 0.0% | 0.05% | -30.0% |
| Q1 2014 | $177,000 | -21.7% | 50,550 | 0.0% | 0.07% | -23.1% |
| Q4 2013 | $226,000 | +10.2% | 50,550 | 0.0% | 0.09% | +1.1% |
| Q3 2013 | $205,000 | -2.4% | 50,550 | 0.0% | 0.09% | -11.8% |
| Q2 2013 | $210,000 | – | 50,550 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |